company background image
RYM

Ryman Healthcare NZSE:RYM Stock Report

Last Price

NZ$9.20

Market Cap

NZ$4.6b

7D

2.5%

1Y

-28.2%

Updated

27 Jun, 2022

Data

Company Financials +
RYM fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance5/6
Financial Health1/6
Dividends4/6

RYM Stock Overview

Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia.

Ryman Healthcare Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ryman Healthcare
Historical stock prices
Current Share PriceNZ$9.20
52 Week HighNZ$15.85
52 Week LowNZ$8.23
Beta0.94
1 Month Change-8.91%
3 Month Change-0.65%
1 Year Change-28.24%
3 Year Change-22.03%
5 Year Change10.31%
Change since IPO3,307.41%

Recent News & Updates

Shareholder Returns

RYMNZ HealthcareNZ Market
7D2.5%1.3%1.7%
1Y-28.2%-13.4%-17.4%

Return vs Industry: RYM underperformed the NZ Healthcare industry which returned -13.4% over the past year.

Return vs Market: RYM underperformed the NZ Market which returned -17.4% over the past year.

Price Volatility

Is RYM's price volatile compared to industry and market?
RYM volatility
RYM Average Weekly Movement6.5%
Healthcare Industry Average Movement4.2%
Market Average Movement4.4%
10% most volatile stocks in NZ Market8.6%
10% least volatile stocks in NZ Market2.9%

Stable Share Price: RYM is more volatile than 75% of NZ stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: RYM's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of NZ stocks.

About the Company

FoundedEmployeesCEOWebsite
19846,700Richard Umbershttps://www.rymanhealthcare.co.nz

Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company’s villages provide a range of retirement living and care options, such as independent townhouses and apartments, and serviced apartments, as well as a care center, which offers rest homes, hospitals, dementia-level care, and respite and day care services. Its villages also provide all-weather bowling green, indoor heated swimming pool and spa, gym, internal atrium, beauty and hairdressing salons, library, dining room, internet café, bar, lounges, croquet laws, shops, and movie theatre facilities.

Ryman Healthcare Fundamentals Summary

How do Ryman Healthcare's earnings and revenue compare to its market cap?
RYM fundamental statistics
Market CapNZ$4.57b
Earnings (TTM)NZ$692.87m
Revenue (TTM)NZ$508.76m

6.6x

P/E Ratio

9.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
RYM income statement (TTM)
RevenueNZ$508.76m
Cost of RevenueNZ$466.24m
Gross ProfitNZ$42.52m
Other Expenses-NZ$650.35m
EarningsNZ$692.87m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.39
Gross Margin8.36%
Net Profit Margin136.19%
Debt/Equity Ratio75.8%

How did RYM perform over the long term?

See historical performance and comparison

Dividends

2.4%

Current Dividend Yield

16%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is RYM undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for RYM?

Other financial metrics that can be useful for relative valuation.

RYM key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue14x
Enterprise Value/EBITDA205.7x
PEG Ratio-1.3x

Price to Earnings Ratio vs Peers

How does RYM's PE Ratio compare to its peers?

RYM PE Ratio vs Peers
The above table shows the PE ratio for RYM vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average14.4x
SUM Summerset Group Holdings
4.1x-46.7%NZ$2.2b
ARV Arvida Group
5.4x-37.3%NZ$1.1b
OCA Oceania Healthcare
11.3x14.2%NZ$692.6m
RAD Radius Residential Care
36.8xn/aNZ$98.3m
RYM Ryman Healthcare
6.6x-5.0%NZ$4.6b

Price-To-Earnings vs Peers: RYM is good value based on its Price-To-Earnings Ratio (6.6x) compared to the peer average (14.4x).


Price to Earnings Ratio vs Industry

How does RYM's PE Ratio compare vs other companies in the Oceanian Healthcare Industry?

Price-To-Earnings vs Industry: RYM is good value based on its Price-To-Earnings Ratio (6.6x) compared to the NZ Healthcare industry average (11.2x)


Price to Earnings Ratio vs Fair Ratio

What is RYM's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

RYM PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio6.6x
Fair PE Ratio13.5x

Price-To-Earnings vs Fair Ratio: RYM is good value based on its Price-To-Earnings Ratio (6.6x) compared to the estimated Fair Price-To-Earnings Ratio (13.5x).


Share Price vs Fair Value

What is the Fair Price of RYM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: RYM (NZ$9.2) is trading above our estimate of fair value (NZ$6.38)

Significantly Below Fair Value: RYM is trading above our estimate of fair value.


Price to Earnings Growth Ratio

PEG Ratio: RYM's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Discover undervalued companies

Future Growth

How is Ryman Healthcare forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-5.0%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: RYM's earnings are forecast to decline over the next 3 years (-5% per year).

Earnings vs Market: RYM's earnings are forecast to decline over the next 3 years (-5% per year).

High Growth Earnings: RYM's earnings are forecast to decline over the next 3 years.

Revenue vs Market: RYM's revenue (14.8% per year) is forecast to grow faster than the NZ market (6.7% per year).

High Growth Revenue: RYM's revenue (14.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: RYM's Return on Equity is forecast to be low in 3 years time (8.8%).


Discover growth companies

Past Performance

How has Ryman Healthcare performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


8.7%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: RYM has a large one-off gain of NZ$745.9M impacting its March 31 2022 financial results.

Growing Profit Margin: RYM's current net profit margins are higher than last year (92.8%).


Past Earnings Growth Analysis

Earnings Trend: RYM's earnings have grown by 8.7% per year over the past 5 years.

Accelerating Growth: RYM's earnings growth over the past year (63.8%) exceeds its 5-year average (8.7% per year).

Earnings vs Industry: RYM earnings growth over the past year (63.8%) exceeded the Healthcare industry 51.7%.


Return on Equity

High ROE: RYM's Return on Equity (20.2%) is considered high.


Discover strong past performing companies

Financial Health

How is Ryman Healthcare's financial position?

Financial Health Score

1/6

Financial Health Score 1/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: RYM's short term assets (NZ$761.1M) do not cover its short term liabilities (NZ$1.1B).

Long Term Liabilities: RYM's short term assets (NZ$761.1M) do not cover its long term liabilities (NZ$6.5B).


Debt to Equity History and Analysis

Debt Level: RYM's net debt to equity ratio (74.4%) is considered high.

Reducing Debt: RYM's debt to equity ratio has increased from 51.2% to 75.8% over the past 5 years.

Debt Coverage: RYM's debt is well covered by operating cash flow (22.5%).

Interest Coverage: RYM's interest payments on its debt are not well covered by EBIT (0.2x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Ryman Healthcare current dividend yield, its reliability and sustainability?

Dividend Score

4/6

Dividend Score 4/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


2.43%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: RYM's dividend (2.43%) isn’t notable compared to the bottom 25% of dividend payers in the NZ market (3.02%).

High Dividend: RYM's dividend (2.43%) is low compared to the top 25% of dividend payers in the NZ market (6.25%).


Stability and Growth of Payments

Stable Dividend: RYM's dividends per share have been stable in the past 10 years.

Growing Dividend: RYM's dividend payments have increased over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (16.2%), RYM's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (46.9%), RYM's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

1.2yrs

Average management tenure


CEO

Richard Umbers

0.67

Tenure

NZ$1,187,835

Compensation

Mr. Richard Umbers has been the Group Chief Executive at Ryman Healthcare Limited since joining in October 2021. He served as the Chief Executive Officer and Managing Director of Myer Holdings Limited sinc...


CEO Compensation Analysis

Compensation vs Market: Richard's total compensation ($USD750.32K) is below average for companies of similar size in the NZ market ($USD1.54M).

Compensation vs Earnings: Insufficient data to compare Richard's compensation with company performance.


Leadership Team

Experienced Management: RYM's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Board Members

Experienced Board: RYM's board of directors are considered experienced (6.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: RYM insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Ryman Healthcare Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Ryman Healthcare Limited
  • Ticker: RYM
  • Exchange: NZSE
  • Founded: 1984
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: NZ$4.575b
  • Shares outstanding: 497.26m
  • Website: https://www.rymanhealthcare.co.nz

Number of Employees


Location

  • Ryman Healthcare Limited
  • Airport Business Park
  • 92 Russley Road
  • Christchurch
  • 8042
  • New Zealand

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/27 00:00
End of Day Share Price2022/06/27 00:00
Earnings2022/03/31
Annual Earnings2022/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.